Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
about
Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic StudyImpact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study.Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults.The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisEffect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.Monitoring of Renal Function among HIV-Infected Patients Receiving Tenofovir in a Resource-Limited Setting.Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up.Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo.
P2860
Q28550681-AC5A314E-EDA3-4F66-952F-865EC7122012Q31028855-48349089-CD8D-4E7E-AABA-2EAF32CF2FF1Q33734997-7A100307-D68D-480F-AC73-EBB1D506E563Q34126724-EE2AF327-843B-4E9F-8BC4-37CB33228888Q35040358-ED09E194-FC88-4D12-8CE0-BFD9A016AC63Q35102254-77882258-7908-452A-9A66-0981D10016EDQ35906897-78B8CC63-0187-44FC-9CA8-4DAF37A42182Q36463811-28580868-CB20-46AB-AB78-6A2FEA72FA59Q37713060-E38EB621-FADE-40B3-8782-090CB4A57BF0Q41201528-0637C693-F7F5-4FCC-8F28-0B71208DA123Q44172482-F295EF24-31A9-40CA-9D48-64367CA0B397Q45400742-C69BE0E4-514D-4F7B-8D27-AC1842898892Q47151132-F5CD0D7A-4299-402A-84A7-FA7D86A4A230
P2860
Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Incidence and risk factors for ...... patients with low-body weight.
@en
Incidence and risk factors for ...... patients with low-body weight.
@nl
type
label
Incidence and risk factors for ...... patients with low-body weight.
@en
Incidence and risk factors for ...... patients with low-body weight.
@nl
prefLabel
Incidence and risk factors for ...... patients with low-body weight.
@en
Incidence and risk factors for ...... patients with low-body weight.
@nl
P2093
P1433
P1476
Incidence and risk factors for ...... patients with low-body weight.
@en
P2093
Chureeratana Bowonwatanuwong
Kessarin Chaisiri
Narat Kasettratat
P304
P356
10.2174/157016210793499259
P577
2010-10-01T00:00:00Z